-
Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT GuidelinesY Ueki, A Karagiannis, C Zanchin et al. -
Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA studyJansen H, Jänsch A, Koenig W et al.
-
Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications ConferenceJA Doll , RS Hira , KE Kearney et al.
-
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart FailureYancy CW, Jessup M, Bozkurt B et al.
-
Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysisM Gaudino, I Hameed, ME Farkouh et al.
-
Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 YearsRA Buiten, EH Ploumen, P Zocca et al.
-
Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease RegistryLB Daniels, JT Ren, K Kumar et al.
-
A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting StentsYL Han, B Xu, NeoVas Randomized Controlled Trial Investigators
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
